IP Library Granted Patent US 6,914,124
Granted Patent B2
US 6,914,124 · App. 09/777,317 · Granted Jul 5, 2005

Tetracycline-regulated transcriptional activator fusion proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,914,124
App. No.
09/777,317
Granted
Jul 5, 2005
Kind
B2
Abstract

A method for regulating expression of a tet operator-linked gene in a cell of a subject is disclosed. In one embodiment, the method involves introducing into the cell a nucleic acid molecule encoding a tetracycline-controllable transactivator (tTA), the tTA comprising a Tet repressor operably linked to a polypeptide which directly or indirectly activates transcription in eucaryotic cells; and modulating the concentration of a tetracycline, or analogue thereof, in the subject. Alternatively, in another embodiment, the method involves obtaining the cell from the subject, introducing into the cell a first nucleic acid molecule which operatively links a gene to at least one tet operator sequence, introducing into the cell a second nucleic acid molecule encoding a tTA, to form a modified cell, administering the modified cell to the subject, and modulating the concentration of a tetracycline, or analogue thereof, in the subject. The first and second nucleic acid molecule can be within a single molecule (e.g., in the same vector) or on separate molecules.

Claims (5)

1. A fusion protein which activates transcription comprising a first polypeptide which is a Tet repressor operatively linked to a second polypeptide which activates transcription in eukaryotic cells.

2. The protein of claim 1 , wherein the Tet repressor is a Tn10-derived Tet repressor.

3. The protein of claim 1 , wherein the second polypeptide comprises a transcription activation domain of herpes simplex virion protein 16.

4. The protein of claim 2 , wherein the second polypeptide comprises the C-terminal 130 amino acids of herpes simplex virion protein 16.

5. The protein of claim 1 , wherein the second polypeptide comprises a transcription activation domain selected from the group consisting of an acidic transcription activation domain, a proline-rich transcription activation domain, a serine/threonine-rich transcription activation domain and a glutamine-rich transcription activation domain.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2004
From: ABBOTT GMBH & CO. KG
To: TET SYSTEMS HOLDING GMBH & CO. KG
Reel/Frame 015370/0860 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2003
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO., KG
Reel/Frame 013718/0861 →